Since the first days of the pandemic, the COVID-19 genome has undergone transformations which is normal for all viruses. Most of these changes don't help so the mutations are abandoned, but some specific changes are now a great concern except vaccines are already available.

This study deals with three mutations of the Epsilon coronavirus spike proteins that allows it to diminish the effectiveness of antibodies to prevent infection. These variations will impact how well vaccines prevent transmission of the disease.

It is a concern for scientists that may bring about a serious alteration in the genome beyond the current variant causing concern now.

Variants might come about by chance

Think of mutations as a game of chance, and sometimes a SARS-CoV-2 variant has the right mutation to get the job done. A variant that will bypass and render these monoclonal antibodies are used in clinics. It will lessen the efficacy of the immunity of inoculated individuals gained from vaccines, reported Eurekalert.

Researchers outlined how a virus would use several ways to fool the immune system. Knowing how epsilon variants work from their infection process, how it has evolved from the first type discovered in the pandemic's early days. This is important to see what happens next as the virus changes.

Taking necessary steps to identifying the Epsilon variants and their changes and how it infects humans is crucial to know more ways to kill it.

Read also: Alternative COVID-19 Vaccine That Uses T-Cells Will Likely Target Mutant Variants

Other details how evasion is evolved

One study, led by David Veesler's lab in the Department of Biochemistry, from the University of Washington, with Luca Piccoli and Davide Corti linked to Vir Biotechnology, was involved in an international study.

An investigation by the team look into the molecular conformation and infection process of SARS-like coronaviruses for a few years. They studied how immune systems would assault the taking over of viruses, also the resulting evolution that will evade cellular defenses, cited Science Daily.

Based on recent data, the Epsilon variant uses an indirect way to infect, with an unusual way to stop antibodies, said the researchers. Their findings are published as a First Release paper in Science.

It was concluded that a molecular clock timed the forming of a precursor to the Epsilon variant in May of 2020 in California. During the summer of 2020, there were two types which are B.1.427/B.1.429 lineages.

Soon after the succeeding infections has increased swiftly, and this variant was dominant in the US. Later, the SARS-CoV-2 variant is now active in 34 other countries via transmission, noted News Medical.

Studying Epsilon Type

Tests were done on the variant to know more about it in depth. It was exposed to the plasma of people who were exposed to the coronavirus and those who are vaccinated to check further. Results show that the variant had dodged the antibodies by 2 to 2.5-fold, which means it survives the immune response.

Compared to the original coronavirus (SARS-CoV-2), Epsilon will use the spike proteins on the virus surface and pierce a host cell. Mutations in the spike glycoproteins are key to avoid antibodies.

If the antibodies cannot destroy the spike of the virus, then it will fail and allow the spikes to enter the cell wall causing a takeover of the host cells.

If identifying the Epsilon variants and their changes show that it is an evolved immune evasion, certain ways must be done to stop it from evolving worse variants.

Related article: Unvaccinated People Can Become "Variant Factories" for COVID-19, Possible Source of Worse Mutations